Athira Pharma (ATHA) Short Interest Ratio & Short Volume → Just Released: Insider's Secret to Trading Options (From Schaeffer’s Research) (Ad) Free ATHA Stock Alerts $2.01 -0.03 (-1.47%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Athira Pharma Short Interest DataCurrent Short Volume1,010,000 sharesPrevious Short Volume979,300 sharesChange Vs. Previous Month+3.13%Dollar Volume Sold Short$2.77 millionShort Interest Ratio / Days to Cover2.5Last Record DateMarch 31, 2024Outstanding Shares38,330,000 sharesFloat Size35,320,000 sharesShort Percent of Float2.86%Today's Trading Volume79,001 sharesAverage Trading Volume387,328 sharesToday's Volume Vs. Average20% Short Selling Athira Pharma ? Sign up to receive the latest short interest report for Athira Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatATHA Short Interest Over TimeATHA Days to Cover Over TimeATHA Percentage of Float Shorted Over Time Ad Wealthpin ProOne trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. Athira Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20241,010,000 shares $2.77 million +3.1%2.9%2.5 $2.74 3/15/2024979,300 shares $2.57 million +25.0%2.8%2.2 $2.62 2/29/2024783,600 shares $3.02 million +20.5%2.2%2 $3.85 2/15/2024650,300 shares $2.38 million -9.4%1.8%1.9 $3.66 1/31/2024717,600 shares $2.27 million +39.6%2.1%2.2 $3.17 1/15/2024513,900 shares $1.54 million +25.4%1.5%1.6 $3.00 Get the Latest News and Ratings for ATHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Athira Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023409,900 shares $996,057.00 -16.6%1.2%1.4 $2.43 12/15/2023491,600 shares $1.14 million -1.6%1.4%2.3 $2.31 11/30/2023499,600 shares $719,424.00 +3.0%1.4%2.7 $1.44 11/15/2023484,900 shares $770,991.00 -8.8%1.4%2.9 $1.59 10/31/2023531,500 shares $829,140.00 -6.2%1.5%3.6 $1.56 10/15/2023566,700 shares $1.01 million -23.6%1.6%4 $1.79 9/30/2023741,900 shares $1.50 million -7.6%2.1%5.1 $2.02 9/15/2023803,300 shares $1.62 million -2.5%2.3%5.3 $2.02 8/31/2023823,500 shares $1.84 million -17.3%2.3%3.4 $2.23 8/15/2023996,000 shares $2.66 million -16.3%2.8%3.8 $2.67 7/31/20231,190,000 shares $3.47 million -3.3%3.4%4.7 $2.92 7/15/20231,230,000 shares $3.78 million +7.0%3.5%4.9 $3.07 6/30/20231,150,000 shares $3.39 million -46.0%3.3%4.4 $2.95 6/15/20232,130,000 shares $6.48 million +3.9%6.1%7.7 $3.04 5/31/20232,050,000 shares $5.68 million No Change5.8%9 $2.77 5/15/20232,050,000 shares $5.88 million -5.5%5.8%9.6 $2.87 4/30/20232,170,000 shares $6.05 million -1.8%6.4%9.6 $2.79 4/15/20232,210,000 shares $5.68 million -9.4%6.5%8.3 $2.57 3/31/20232,440,000 shares $6.10 million +8.4%6.8%7.7 $2.50 3/15/20232,250,000 shares $6.05 million +9.8%N/A6.9 $2.69 2/28/20232,050,000 shares $6.31 million +5.7%5.5%6.3 $3.08 2/15/20231,940,000 shares $6.44 million +4.9%5.2%5.9 $3.32 1/31/20231,850,000 shares $7.47 million +20.9%5.0%5.6 $4.04 1/15/20231,530,000 shares $5.89 million No Change4.1%4.8 $3.85 12/30/20221,530,000 shares $4.85 million -1.9%4.1%5.5 $3.17 12/15/20221,560,000 shares $4.96 million -4.3%N/A5.9 $3.18 11/30/20221,630,000 shares $5.07 million -3.0%N/A6.4 $3.11 11/15/20221,680,000 shares $5.29 million -6.2%N/A6.9 $3.15 10/31/20221,790,000 shares $5.92 million -2.2%N/A7 $3.31 10/15/20221,830,000 shares $5.87 million +0.6%5.1%5.9 $3.21 9/30/20221,820,000 shares $5.41 million -2.2%5.1%5.6 $2.97 9/15/20221,860,000 shares $6.64 million +3.3%5.2%3.3 $3.57 8/31/20221,800,000 shares $6.08 million -1.1%5.0%1.9 $3.38 8/15/20221,820,000 shares $7.10 million +2.8%5.1%1.9 $3.90The Hard Truth About Investing For Retirement (Ad)Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! ATHA Short Interest - Frequently Asked Questions What is Athira Pharma's current short interest? Short interest is the volume of Athira Pharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 1,010,000 shares of ATHA short. 2.86% of Athira Pharma's shares are currently sold short. Learn More on Athira Pharma's current short interest. What is a good short interest ratio for Athira Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATHA shares currently have a short interest ratio of 2.0. Learn More on Athira Pharma's short interest ratio. Which institutional investors are shorting Athira Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Athira Pharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Athira Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.86% of Athira Pharma's floating shares are currently sold short. Is Athira Pharma's short interest increasing or decreasing? Athira Pharma saw a increase in short interest in March. As of March 31st, there was short interest totaling 1,010,000 shares, an increase of 3.1% from the previous total of 979,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Athira Pharma's float size? Athira Pharma currently has issued a total of 38,330,000 shares. Some of Athira Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Athira Pharma currently has a public float of 35,320,000 shares. How does Athira Pharma's short interest compare to its competitors? 2.86% of Athira Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Athira Pharma: Cognition Therapeutics, Inc. (0.53%), Passage Bio, Inc. (3.57%), Gritstone bio, Inc. (9.40%), Precision BioSciences, Inc. (8.03%), Turnstone Biologics Corp. (4.74%), Atara Biotherapeutics, Inc. (9.41%), Elutia Inc. (0.14%), Instil Bio, Inc. (0.22%), Curis, Inc. (0.85%), Genenta Science S.p.A. (0.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Athira Pharma stock? Short selling ATHA is an investing strategy that aims to generate trading profit from Athira Pharma as its price is falling. ATHA shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Athira Pharma? A short squeeze for Athira Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATHA, which in turn drives the price of the stock up even further. How often is Athira Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATHA, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Cognition Therapeutics Short Interest Data Passage Bio Short Interest Data Gritstone bio Short Interest Data Precision BioSciences Short Interest Data Turnstone Biologics Short Interest Data Atara Biotherapeutics Short Interest Data Elutia Short Interest Data Instil Bio Short Interest Data Curis Short Interest Data Genenta Science Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATHA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders